Impact Report

Overview

The report covers Pfizer's 2024 responsible-business performance across governance, climate, sustainable medicines, global health, and colleague topics. It highlights a commitment to reduce Scope 1 and 2 GHG emissions by 46% from 2019 levels by 2030, with 14% renewable electricity sourced in 2024. The report also records two work-related fatalities in 2024 and describes Board and committee oversight of responsible business practices.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2024
Period: 1 January 2024 – 31 December 2024
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level
SBTi status

Materiality

Assessment
Basis

Assurance

Provider
Level
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services